Danville, CA, United States of America

Weijun Feng

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2021)
  • Danville, CA (US) (2021 - 2022)

Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Weijun Feng: A Pioneer in Therapeutic Delivery Systems

Introduction: Weijun Feng is an innovative inventor based in Danville, CA, whose work has significantly impacted the field of pharmaceutical delivery systems. With a remarkable portfolio of 8 patents, he is at the forefront of developing advanced methods for delivering therapeutic agents effectively to treat various medical conditions.

Latest Patents: Weijun Feng's latest patents showcase his ingenuity and commitment to improving therapeutic interventions. One notable patent is titled "Cholix-derived carriers for oral delivery of heterologous payload." This invention provides a delivery construct that couples a carrier to a heterologous payload, enabling the transportation of therapeutic substances across polarized epithelial cells, particularly in the gut. Such delivery constructs are crucial for developing improved oral medications targeting inflammatory and autoimmune diseases.

Another significant patent is "Compositions, formulations and interleukin production and purification." This patent details cholix-IL-10 fusion proteins and their distinct physiological responses when administered. It includes oral formulations designed for the site-specific release of therapeutic proteins, particularly in the small intestines or colon. The methodologies for purifying IL-10 delivery constructs ensure a high percentage of biologically active forms, which is vital for their efficacy.

Career Highlights: Weijun Feng’s work at Applied Molecular Transport Inc. exemplifies his dedication to advancing drug delivery technologies. His 8 patents demonstrate a consistent effort to innovate in the field, particularly in developing oral delivery systems that can enhance patient outcomes. His focus on creating solutions that address complex diseases positions him as a leading figure in pharmaceutical research.

Collaborations: Throughout his career, Weijun Feng has collaborated with esteemed colleagues, including Randall J. Mrsny and Tahir Mahmood. These partnerships have undoubtedly contributed to the advancement of his research and patent developments, reflecting a collaborative spirit that is essential in the field of biomedical sciences.

Conclusion: In conclusion, Weijun Feng is a notable inventor whose contributions to the field of therapeutic delivery are shaping the future of medicine. His innovative patents, along with his collaborative endeavors at Applied Molecular Transport Inc., underscore his pivotal role in advancing pharmaceutical technologies. As he continues to explore new frontiers in drug delivery systems, his work promises to improve therapeutic outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…